however , accumulation of peritoneal cells and activation of peritoneal macrophages by compound 309 was weaker than that by 6-o-b30-mdp , suggesting that 309 as an immunoadjuvant is more suitable for vaccination in terms of its stronger enhancement of antibody formation and lower induction of inflammatory response than 6-o-b30-mdp .
C0031153
peritoneal
C0206190
peritoneal macrophages